NAYA Biosciences Inc - Multiplikator EV/Sales NAYA

Logo perusahaan publik NAYA Biosciences Inc. (NAYA)

NAYA Biosciences develops oncology drugs through partnerships with medical centers. The GURU.Markets terminal displays an enterprise value-to-revenue chart, where the value represents the latest figure. NAYA Biosciences seeks alternatives to chemotherapy by activating NK cells. The current R&D stage precludes commercial revenue, shifting business scaling into the realm of increasing fixed costs for scientific research.

NAYA Biosciences Corp - Multiplikator EV/Sales NAYA (periode 04.07.2022 - 20.11.2026)

NAYA (nayabiosciences.com): rincian analitis lan laporan miturut indikator

Analisis wiwitan perusahaan:NAYA (NAYA Biosciences)
Produk asli NAYA Biosciences

For NAYA Biosciences, which is developing the Flex-NK platform for targeted immunotherapy of solid tumors, the potential for technology commercialization serves as a key valuation factor. By analyzing the ratio of Enterprise Value to revenue, an investor can view the market value of the entire business, including net debt, relative to sales, which allows for an assessment of the premium for future growth and the risk of overpayment within M&A transactions.

Analisis pesaing NAYA Biosciences

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales HURA (TuHURA Biosciences, Inc.)|Nilai bisnis marang pendapatan TARA|FATE: Nilai perusahaan marang pendapatan|WHWK (aadibio.com) - Rasio nilai perusahaan marang pendapatan|TCRX (TScan Therapeutics, Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Multiplikator EV/Sales|CVM (CEL-SCI Corporation) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSTX|Multiplikator EV/Sales Radiopharm Theranostics Ltd (RADX)|Multiplikator EV/Sales ARTV (Artiva Biotherapeutics)|Multiplikator EV/Sales Adlai Nortye Ltd. ANL|Veru Inc - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Tempest Therapeutics TPST|XLO: Multiplikator EV/Sales|Enochian BioSciences (RENB) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan MURA|Kairos Pharma Ltd - Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales OKUR|CytoMed Therapeutics Limited (GDTC) - Rasio nilai perusahaan marang dodolan|Multiplikator EV/Sales CRIS (Curis, Inc.)|APLM: Rasio nilai perusahaan marang pendapatan|Tharimmune Corporation - Multiplikator EV/Sales|ADVB: Rasio nilai perusahaan marang pendapatan|GNPX: Multiplikator EV/Sales|CLDI (Calidi Biotherapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Sunshine Biopharma, Inc.|Multiplikator EV/Sales xeneticbio.com|Rasio nilai perusahaan marang pendapatan Salarius (SLRX)|Nilai perusahaan marang pendapatan Purple Biotech PPBT|Rasio nilai perusahaan marang pendapatan American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Multiplikator nilai perusahaan marang pendapatan|Checkpoint Therapeutics Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Nilai perusahaan marang pendapatan|Ikena Oncology, Inc. - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NTBL|VIRX: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan MorphoSys Corporation (MOR)|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan